Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1251 to 1300 of 2500

TitleReference numberPublishedLast updated
Leadless cardiac pacemaker implantation for bradyarrhythmiasIPG626
Superior rectal artery embolisation for haemorrhoidsIPG627
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Neon EEG electrode for EEG monitoring in newbornsMIB155
AlignRT in breast cancer radiotherapyMIB157
Sutureless aortic valve replacement for aortic stenosisIPG624
Flu vaccination: increasing uptakeNG103
Dinutuximab beta for treating neuroblastomaTA538
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaIPG625
Intermediate care including reablementQS173
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537
EndometriosisQS172
Community pharmacies: promoting health and wellbeingNG102
Dupilumab for treating moderate to severe atopic dermatitisTA534
Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healingIPG621
Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healingIPG622
Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fracturesIPG623
Mechanical thrombectomy devices for acute ischaemic strokeMIB153
Remote ECG interpretation consultancy services for cardiovascular diseaseMIB152
Superior capsular augmentation for massive rotator cuff tearsIPG619
Transaxial interbody lumbosacral fusion for severe chronic low back painIPG620
Ocrelizumab for treating relapsing–remitting multiple sclerosisTA533
Medicines management for people receiving social care in the communityQS171
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancerTA531
Airglove air warming system for venous accessMIB151
Biomarker tests to help diagnose preterm labour in women with intact membranesDG33
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapyTA530
SpondyloarthritisQS170
Beta interferons and glatiramer acetate for treating multiple sclerosisTA527
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorIPG617
Laparoscopic ventral mesh rectopexy for internal rectal prolapseIPG618
Dementia: assessment, management and support for people living with dementia and their carersNG97
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's diseaseTA217
ORA G3 to measure corneal hysteresisMIB150
Intranasal phototherapy for allergic rhinitisIPG616
Guselkumab for treating moderate to severe plaque psoriasisTA521
Midostaurin for untreated acute myeloid leukaemiaTA523
Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaTA524
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and overNG36
VIDAvision for lung volume analysis in emphysemaMIB148
Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapyIPG615
Cystic fibrosisQS168
Developmental follow-up of children and young people born pretermQS169
AlignRT for intracranial stereotactic radiosurgeryMIB147
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Promoting health and preventing premature mortality in black, Asian and other minority ethnic groupsQS167

Results per page

  1. 10
  2. 25
  3. 50
  4. All